OptiNose
OptiNose is a Pennsylvania-based pharmaceutical company that develops and commercializes therapeutic products for the treatment of ENT problems and allergies.
Business Model:
Revenue: $77.9M
Employees: 51-200
Industries / Tags:
Detailed OptiNose Information
Geographic Data
Address: 1020 Stony Hill Road
City: Yardley
State: PA
Zip: 19067
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$150M
Raised Total:$401M
Social
Metrics
3,310,147Website Global Rank
4,564Website Monthly Traffic
Twitter Followers
Description
OptiNose is a Pennsylvania-based pharmaceutical company that develops and commercializes therapeutic products for the treatment of ENT problems and allergies.
Contact Phone:
+12673643500
Contact Email:
OptiNose went public on 10/17/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/17/2017
IPO Valuation:
$604M
Ticker Symbol:
OPTN
IPO Price:
$16/share
Amount Raised:
$138M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
